Animal models of the eosinophilia-myalgia syndrome

Journal of Rheumatology

Volumn 23, Issue SUPPL. 46, 1996, Pages 93-98

  Clauw, Daniel J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

animal studies; eosinophilia myalgia syndrome; epidemiology; L tryptophan

Indexed keywords

1,1' ETHYLIDENEBIS(TRYPTOPHAN); 3 (PHENYLAMINO)ALANINE; ALANINE DERIVATIVE; TRYPTOPHAN; UNCLASSIFIED DRUG; 1,1' ETHYLIDENE BIS(TRYPTOPHAN); 1,1'-ETHYLIDENE BIS(TRYPTOPHAN); DRUG DERIVATIVE;

ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; EOSINOPHILIA MYALGIA SYNDROME; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RHESUS MONKEY; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; MACACA; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; EOSINOPHILIA-MYALGIA SYNDROME; MACACA MULATTA; MICE; RATS; TRYPTOPHAN;

EID: 0030255394     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Clauw DJ, Nashel DJ, Umhau A, Katz P: Tryptophan-associated eosinophilia connective tissue disease. A new clinical entity? JAMA 1990;263:1502-6.
2. Silver RM: Eosinophilia-myalgia syndrome, toxic oil syndrome, and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol 1992;4:851-6.
3. Varga J, Jimenez SA, Uitto J: L-tryptophan and the eosinophilia-myalgia syndrome: Current understanding of the etiology and pathogenesis. J Invest Dermatol 1993;100:97S-105S.
4. Kaufman LD, Seidman RJ: L-tryptophan-associated eosinophilia-myalgia syndrome: Perspective of a new illness. Rheum Dis Clin North Am 1991;17:427-41.
5. Philen RM, Hill RH Jr, Flanders WD, et al: Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico. Am J Epidemiol 1993;138:154-9.
6. Kilbourne EM: Eosinophilia-myalgia syndrome: Coming to grips with a new illness. Epidemiol Rev 1992;14:16-36.
7. Crofford LJ, Rader JI, Dalakas MC, et al: L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. J Clin Invest 1990;86:1757-63.
8. Silver RM, Ludwicka A, Hampton M, et al: A murine model of the eosinophilia-myalgia syndrome induced by 1,1′-ethylidenebis (L-tryptophan). J Clin Invest 1994;93:1473-80.
9. Love LA, Rader JL, Crofford LJ, et al: Pathological and immunological effects of ingesting L-tryptophan and 1,1′-ethylidenebis (L-tryptophan) in Lewis rats. J Clin Invest 1993;91:804-11.
10. DeSchryver-Kecskemeti K, Gramlich TL, Crofford LJ, et al: Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with L-tryptophan implicated in human eosinophiiia myalgia syndrome. Mod Pathol 1991;4:354-7.
11. Ito J, Hosaki Y, Torigoe Y, Sakimoto K: Identification of substances formed by decomposition of peak E substance in tryptophan. Food Chem Toxicol 1992;30:71-81.
12. Clauw DJ, Scott L, Manz H, Kagan E, Katz P: A rat feeding study using tryptophan implicated as causal in the eosinophilia myalgia syndrome (abstr). Arthritis Rheum 1992;35(5S):25S.
13. Jones MM, Vivado AK, Thomas PA, Waldschmidt TJ: Anti-IL-5 antibody ablates the eosinophilia induced by L-tryptophan administration in mice (abstr). Arthritis Rheum 1994;(suppl)37:274.
14. Emslie-Smith AM, Mayeno AN, Nakano S, Gleich GJ, Engel AG: 1,1′-Ethylidenebis[tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia-myalgia syndrome. Neurology 1994;44:2390-2.
15. Mayeno AN, Belongia EA, Lin F, Lundy SK, Gleich GJ: 3-(Phenylamino) alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: A link to the toxic oil syndrome? Mayo Clin Proc 1992;67:1134-9.
16. Flockhart DA, Clauw DJ, Buchen E, Harris J, Woosley RL: Pharmacogenetic characteristics of the eosinophilia myalgia. Clin Pharm Ther 1994;56:398-405.
17. Clauw DJ, Blank C, Tefft M, et al: Features of the eosinophilia myalgia syndrome in a mouse model (abstr). Arthritis Rheum 1993;(suppl)36:A100.
18. Anderson ST, Klein EC: Eosinophilic fasciitis in a rhesus macaque. Arthritis Rheum 1992;35:714-6.
19. Silver RM, McKinley K, Smith EA, et al: Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome. Arthritis Rheum 1992;35:1097-105.
20. Silver RM, Sutherland SE, Carreira P, Heyes MP: Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome. J Rheumatol 1992;19:69-73.